Australian Translational Medicinal Chemistry Facility (ATMCF): call for collaborative projects 2020

The ATMCF is a national drug discovery capability that applies medicinal chemistry expertise to translate biomedical research towards clinical relevance. Facilitated by Therapeutic Innovation Australia (TIA), and based at The Monash Institute of Pharmaceutical Sciences (MIPS), Parkville, the ATMCF collaborates with researchers to identify and synthesize bioactive compounds (small molecules) which are fed into medicinal chemistry optimization against a range of potency, selectivity and pharmacokinetic criteria.

The ATMCF provides Australian researchers with an opportunity to:

  • access subsidised medicinal chemistry
  • access the Therapeutic Innovation Australia (TIA) Pipeline Accelerator for further cost reductions
  • work with a team of medicinal chemists who have a proven track record in drug discovery and commercialisation outcomes

Submission requirements & due date

Further information

Need help?

This entry was posted in Access to Facilities, Equipment & Infrastructure, Funding by Award Type, Funding by Faculty, Health & Medical Sciences. Bookmark the permalink.

Comments are closed.